144 related articles for article (PubMed ID: 29274441)
1. Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Johari B; Mohd Ismail N
Eur J Pharm Sci; 2018 Mar; 114():245-254. PubMed ID: 29274441
[TBL] [Abstract][Full Text] [Related]
2. Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Mohd Ismail N
Data Brief; 2018 Jun; 18():523-554. PubMed ID: 29896529
[TBL] [Abstract][Full Text] [Related]
3. Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension.
Marcus AJ; Iezhitsa I; Agarwal R; Vassiliev P; Spasov A; Zhukovskaya O; Anisimova V; Ismail NM
Eur J Pharmacol; 2019 May; 850():75-87. PubMed ID: 30716317
[TBL] [Abstract][Full Text] [Related]
4. Relationship between intraocular pressure lowering effect and chemical structure of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole derivatives.
Vassiliev P; Iezhitsa I; Agarwal R; Marcus AJ; Spasov A; Zhukovskaya O; Anisimova V
Data Brief; 2018 Jun; 18():340-347. PubMed ID: 29896521
[TBL] [Abstract][Full Text] [Related]
5. Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension.
Razali N; Agarwal R; Agarwal P; Kumar S; Tripathy M; Vasudevan S; Crowston JG; Ismail NM
Clin Exp Ophthalmol; 2015; 43(1):54-66. PubMed ID: 24995479
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma.
Abbhi V; Saini L; Mishra S; Sethi G; Kumar AP; Piplani P
Bioorg Med Chem; 2017 Nov; 25(21):6071-6085. PubMed ID: 29033348
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits.
Pate DW; Järvinen K; Urtti A; Jarho P; Järvinen T
Curr Eye Res; 1995 Sep; 14(9):791-7. PubMed ID: 8529418
[TBL] [Abstract][Full Text] [Related]
8. Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination.
Fuwa M; Ueda K; Akaishi T; Yamashita N; Kirihara T; Shimazaki A; Mano H; Kawazu K
PLoS One; 2016; 11(7):e0158797. PubMed ID: 27383260
[TBL] [Abstract][Full Text] [Related]
9. Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Exp Eye Res; 2009 Mar; 88(3):504-11. PubMed ID: 19056382
[TBL] [Abstract][Full Text] [Related]
10. Ocular hypotensive effects of topically administered agmatine in a chronic ocular hypertensive rat model.
Hong S; Kim CY; Lee WS; Shim J; Yeom HY; Seong GJ
Exp Eye Res; 2010 Jan; 90(1):97-103. PubMed ID: 19782071
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug.
Takagi Y; Nakajima T; Shimazaki A; Kageyama M; Matsugi T; Matsumura Y; Gabelt BT; Kaufman PL; Hara H
Exp Eye Res; 2004 Apr; 78(4):767-76. PubMed ID: 15037111
[TBL] [Abstract][Full Text] [Related]
12. Association of ocular hypotensive medication types with dynamic contour tonometry and Goldmann applanation tonometry measurements in a glaucoma and ocular hypertensive population.
Tzamalis A; Kynigopoulos M; Chalvatzis N; Dimitrakos S; Schlote T
J Ocul Pharmacol Ther; 2013 Feb; 29(1):41-7. PubMed ID: 23066787
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension.
Huang P; Xu Y; Wei R; Li H; Tang Y; Liu J; Zhang SS; Zhang C
J Glaucoma; 2011 Mar; 20(3):183-8. PubMed ID: 20440217
[TBL] [Abstract][Full Text] [Related]
14. Asymmetry of 24-hour intraocular pressure reduction by topical ocular hypotensive medications in fellow eyes.
Liu JH; Realini T; Weinreb RN
Ophthalmology; 2011 Oct; 118(10):1995-2000. PubMed ID: 21676464
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effect of hypertonic hydroxyethyl starch and mannitol on the intraocular pressure in healthy normotensive dogs and the effect of hypertonic hydroxyethyl starch on the intraocular pressure in dogs with primary glaucoma.
Volopich S; Mosing M; Auer U; Nell B
Vet Ophthalmol; 2006; 9(4):239-44. PubMed ID: 16771759
[TBL] [Abstract][Full Text] [Related]
16. Effect of PF-04217329 a prodrug of a selective prostaglandin EP(2) agonist on intraocular pressure in preclinical models of glaucoma.
Prasanna G; Carreiro S; Anderson S; Gukasyan H; Sartnurak S; Younis H; Gale D; Xiang C; Wells P; Dinh D; Almaden C; Fortner J; Toris C; Niesman M; Lafontaine J; Krauss A
Exp Eye Res; 2011 Sep; 93(3):256-64. PubMed ID: 21376717
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Characterization of Omidenepag Isopropyl, a Novel Selective EP2 Receptor Agonist, as an Ocular Hypotensive Agent.
Kirihara T; Taniguchi T; Yamamura K; Iwamura R; Yoneda K; Odani-Kawabata N; Shimazaki A; Matsugi T; Shams N; Zhang JZ
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):145-153. PubMed ID: 29332128
[TBL] [Abstract][Full Text] [Related]
18. Nitrovasodilators as a new class of ocular hypotensive agents.
Nathanson JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):956-65. PubMed ID: 1532035
[TBL] [Abstract][Full Text] [Related]
19. The effects of prostaglandin analogues on IOP in prostanoid FP-receptor-deficient mice.
Ota T; Aihara M; Narumiya S; Araie M
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4159-63. PubMed ID: 16249494
[TBL] [Abstract][Full Text] [Related]
20. [Alterations of intraocular pressure in comparison of self- and external-administered topical antiglaucomatosa during diurnal intraocular pressure measurements].
Böhm MR; Lill TM; Eter N; Prokosch-Willing V
Klin Monbl Augenheilkd; 2014 Aug; 231(8):810-7. PubMed ID: 25133559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
